The MIRROR Registry: Minimally Invasive IntRaceRebral HemORrhage Evacuation

Purpose

This registry will study the use of the Aurora® Surgiscope to provide surgical access and visualization in minimally invasive removal of hematoma in the brain. Many methods of hematoma removal are available and will be based on surgeon preference. The impact of patient selection and time to surgery from last known well time will be explored.

Condition

  • Supratentorial Hemorrhage

Eligibility

Eligible Ages
Over 18 Years
Eligible Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Subject Age is > 18 - Subject with a Head CT that demonstrates an acute, spontaneous, primary, supratentorial ICH of volume > 20 mL, assessed via standard of care techniques - Subject Surgery can be initiated within 24 hours of the last known well time or, in patients with wake-up onset, within 24 hours of the time the patient awoke with symptoms. - Subject has a NIHSS score > 5 - Subject has a baseline Modified Rankin Scale (mRS) Score ≤ 2 - Subject with a CT Angiography demonstrating no vascular malformation

Exclusion Criteria

  • Subject has an underlying vascular lesion defined as causative source of ICH - Subject has a profound neurological deficit defined as fixed/dilated pupils or bilateral extensor motor posturing - Subject has an Infratentorial or brainstem ICH - Subject has a known life expectancy < 6 months - Subject has an uncorrectable coagulopathy - Subject has a mechanical heart valve - Subject is pregnant - Subject participates in another concurrent interventional clinical trial - Subject who is unable to meet study follow-up requirements

Study Design

Phase
Study Type
Observational
Observational Model
Case-Only
Time Perspective
Prospective

Arm Groups

ArmDescriptionAssigned Intervention
AURORA Aurora® Surgiscope used for MIS evacuation of supratentorial hematoma
  • Device: Aurora Surgiscope System
    MIS evacuation of hematoma using the Aurora Surgiscope System

Recruiting Locations

Providence Health
Burbank 5331835, California 5332921 91505
Contact:
Jeffrey Figueroa
Jeffrey.Figueroa@providence.org

University of Miami
Miami 4164138, Florida 4155751 33136
Contact:
Adriana Saravia
a.saravia@med.miami.edu

University of South Florida
Tampa 4174757, Florida 4155751 33606
Contact:
Shardonnai Sims
shardonnaisims@tgh.org

Rush University Medical Center
Chicago 4887398, Illinois 4896861 60612
Contact:
Rebecca McWilliams
rebecca_mcwilliams@rush.edu

University of Missouri
Columbia 4381982, Missouri 4398678 65201
Contact:
Brooke Hoffman
hoffmanba@health.missouri.edu

Washington University in St. Louis
St Louis 4407066, Missouri 4398678 63110
Contact:
Ramie Heo
heor@wustl.edu

JFK university
Edison 5097529, New Jersey 5101760 08820
Contact:
Surekha Patel, MBBS

University at Buffalo
Buffalo 5110629, New York 5128638 14260
Contact:
Michaela Laskowski
mlaskowski@ubns.com

Icahn School of Medicine at Mount Sinai
New York 5128581, New York 5128638 10029
Contact:
Emily Svendsen
emily.svendsen@mountsinai.org

University of North Carolina
Chapel Hill 4460162, North Carolina 4482348 27599-1350
Contact:
Patricia Orozco

Cleveland Clinic
Cleveland 5150529, Ohio 5165418 44195
Contact:
Joyce Barmen
barmenj2@ccf.org

University of Oklahoma
Oklahoma City 4544349, Oklahoma 4544379 73104
Contact:
Michael Omini
michael-omini@ouhsc.edu

Pennsylvania State University
Hershey 5193342, Pennsylvania 6254927 17033
Contact:
Olivia Christman

Prisma Health - Upstate
Greenville 4580543, South Carolina 4597040 29601
Contact:
Rosie Gaddy
rosie.gaddy@prismahealth.org

University of Utah
Salt Lake City 5780993, Utah 5549030 84112
Contact:
Andrew Grandemange, MBA

University of Washington - Harborview
Seattle 5809844, Washington 5815135 98104
Contact:
Do Lim
dolim@uw.edu

More Details

NCT ID
NCT04494295
Status
Recruiting
Sponsor
Integra LifeSciences Corporation

Study Contact

Habib Nacer-Chérif
+33626190029
habib.nacercherif@integralife.com